News

Diagnostic and Defense Technology Analysts, Inc. Announces Second Commercialization Project with KTH Royal Institute of Technology in Stockholm.

Diagnostic and Defense Technology Analysts, Inc. (DTA), an international commercialization company based in Lund, Sweden and San Diego, CA, today announced its second project with KTH Holding AB, an investment company managed by the prestigious KTH Royal Institute of Technology in Stockholm.

Diagnostic and Defense Technology Analysts, Inc. Announces Pre-Eminent University as New Client

SAN DIEGO, CA February 15, 2018 --(PR.com)-- Diagnostic and Defense Technology Analysts, Inc. (DTA), based in San Diego, CA and Lund, Sweden, today announced its latest client, Lund University’s research and innovation department - birthplace of technologies such as the artificial kidney, medical ultrasound and Bluetooth.

Diagnostic and Defense Technology Analysts, Inc. (DTA) to work with Lund University’s research and innovation department - birthplace of technologies such as the artificial kidney, medical ultrasound and Bluetooth. DTA is an international commercialization company that provides market intelligence, technology assessments and other commercialization services. They will be using European Comimssion-awarded software tool TechAdvance™ to work with the Lund University team to assess new technologies.

Diagnostic and Defense Technology Analysts, Inc. Introduces New Technology Commercialization Software TechAdvance™, Partnership with Apprimo Co.

SAN DIEGO, CA October 19, 2017— Diagnostic and Defense Technology Analysts, Inc. (DTA), based in San Diego, CA and Lund, Sweden, today announced it will market and support the award-winning TechAdvance™ software tool for technology assessment, commercialization and portfolio management, having recently signed a licensing agreement with Apprimo, a business spin off from Münster University of Applied Sciences that created the software. TechAdvance™ recently won the Europe Innova Award from the European Commission for novel tools and services.

Diagnostic and Defense Technology Analysts, Inc. Announces Partnership with Apprimo

SAN DIEGO, CA October 1, 2017 — Diagnostic and Defense Technology Analysts, Inc. (DTA) today announced a licensing agreement with Apprimo, a business spin-out from Münster University of Applied Sciences. Through this agreement DTA will market and support Apprimo’s on-line software tool TechAdvance™ for technology assessment and portfolio management.

Diagnostic and Defense Technology Analysts, Inc. Wins Commercialization Contract with KTH Holding AB

STOCKHOLM, SWEDEN, October 1, 2017 — KTH Holding AB, a commercialization company under the Royal Institute of Technology in Stockholm, today announced the award of a key commercialization project to Diagnostic and Defense Technology Analysts, Inc. (DTA). The agreement with DTA specifically targets a medical device currently under development at KTH.